Vaccine vs. Wild Measles: No Peer-Reviewed Proof of Reduced Spread or Replication
This post was published by Jon Fleetwood. Please visit his Substack and subscribe to support his work. Follow Jon: Instagram @realjonfleetwood / Twitter @JonMFleetwood / Facebook @realjonfleetwood
Editor’s Note: I’ve run this article through four different artificial intelligence (AI) systems, asking them whether anything I’ve written in this article is false. ChatGPT, Twitter/X’s Grok, Google’s Gemini, and Perplexity all confirm everything below is accurate. Try it yourself: Paste my headline into one of these AIs. Read the response. Then paste the body of my article. Read the response. Ask it if the information is accurate. I’ve provided the responses that all four AIs gave to this question underneath this article’s conclusion.
Despite decades of widespread use and confidence in the measles vaccine, there is a striking gap in the scientific literature: no peer-reviewed studies directly confirm that the vaccine-type measles virus (Edmonston strain) is less infectious or replicates less than the wild-type measles virus (Montefiore strain) in human patients.
This fact raises important questions about assumptions underlying vaccine development and deployment. Without direct evidence, we are left to rely on assumptions rather than definitive proof, which could have serious implications for understanding how the vaccine strain behaves in human populations.
This also raises the possibility that the vaccine-type virus could, in fact, be more infectious and replicate more efficiently than the wild-type virus in certain contexts.
Only Indirect Evidence Suggests Attenuation
Existing studies rely on indirect evidence from laboratory experiments, animal models, and epidemiological observations to suggest that the vaccine strain has attenuated replication. For example:
Gain-of-Function Modifications
The vaccine strain’s ability to bind CD46—a receptor expressed on all nucleated human cells—represents a clear gain-of-function (GOF) adaptation. This receptor shift occurred during tissue culture passaging, enabling the vaccine virus to infect a broader range of cell types compared to the wild-type virus, which primarily targets immune cells via CD150.
Texas Measles Outbreak Raises Questions About Vaccine Design
The ongoing measles outbreak in Texas adds urgency to these unresolved questions about vaccine strain behavior. Texas administered 15,000 more MMR doses this year compared to 2024, yet measles cases have surged beyond last year’s nationwide total. As of late March 2025:
This paradox—more vaccinations coinciding with more measles cases—raises troubling questions about whether factors related to vaccination campaigns could inadvertently contribute to outbreaks:
While most cases involve unvaccinated individuals or those with unknown vaccination status, this outbreak highlights gaps in understanding how vaccination campaigns interact with population dynamics and viral behavior.
Gaps in Research
No peer-reviewed studies have directly compared infection rates or replication efficiency between vaccine-type and wild-type measles viruses in humans. Key unanswered questions include:
Implications for Public Health
While decades of epidemiological data purportedly support the safety and efficacy of measles vaccines, this gap highlights the need for further research to address unresolved questions about vaccine strain behavior. Ethical constraints make direct human trials challenging, but advancements in modeling and genomic analysis could provide insights into these mechanisms.
Conclusion
The absence of direct studies confirming reduced infectivity or replication of the measles vaccine virus compared to the wild-type virus underscores a significant gap in scientific understanding. This fact does not diminish the proven benefits of vaccination but calls for greater transparency and rigorous investigation into assumptions underlying vaccine design.
Without addressing these gaps, we risk overlooking critical aspects of how engineered viruses behave in humans—an oversight that could have far-reaching consequences for public health and scientific integrity.
Furthermore, it raises an unsettling question: Could the vaccine-type measles virus actually be more infectious or replicate more efficiently than its wild-type counterpart?
Until direct studies are conducted, this possibility cannot be definitively ruled out—and recent outbreaks like Texas’s record-breaking surge demand urgent answers about how vaccination campaigns interact with viral dynamics and population immunity.
Your support is crucial in helping us defeat mass censorship. Please consider donating via Locals or check out our unique merch. Follow us on X @ModernityNews.
Source link